ResearcherGuangxi Medical UniversityActive in the last 2 years
Xiubing Chen
Matched on OpenAlex author ID A5055485023. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2023: 2 papers · 2024: 2 papers
Papers 4
- SERPINA1 promotes the invasion, metastasis, and proliferation of pancreatic ductal adenocarcinoma via the PI3K/Akt/NF-κB pathway. Co-author DOI 10.1016/j.bcp.2024.116580↗
- Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway. First author DOI 10.1038/s41598-024-75089-7↗
- Differential Plasma Proteins Identified via iTRAQ-Based Analysis Serve as Diagnostic Markers of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1155/2023/5145152↗
- Identification of ZBTB4 as an immunological biomarker that can inhibit the proliferation and invasion of pancreatic cancer. Co-author DOI 10.1186/s12885-023-10749-x↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Haixing Jiang · 3 shared papers, 2023–2024 · strength 0.60
- Paper Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway. DOI 10.1038/s41598-024-75089-7↗
- Paper Differential Plasma Proteins Identified via iTRAQ-Based Analysis Serve as Diagnostic Markers of Pancreatic Ductal Adeno… DOI 10.1155/2023/5145152↗
- Paper Identification of ZBTB4 as an immunological biomarker that can inhibit the proliferation and invasion of pancreatic can… DOI 10.1186/s12885-023-10749-x↗
- Shanyu Qin · 3 shared papers, 2023–2024 · strength 0.60
- Paper Bidirectional effects of morphine on pancreatic cancer progression via the p38/JNK pathway. DOI 10.1038/s41598-024-75089-7↗
- Paper Differential Plasma Proteins Identified via iTRAQ-Based Analysis Serve as Diagnostic Markers of Pancreatic Ductal Adeno… DOI 10.1155/2023/5145152↗
- Paper Identification of ZBTB4 as an immunological biomarker that can inhibit the proliferation and invasion of pancreatic can… DOI 10.1186/s12885-023-10749-x↗
- Jing Ning · 2 shared papers, 2023–2024 · strength 0.41
- Dan Yang · 1 shared paper, 2024 · strength 0.24
- Lu Jiefu · 1 shared paper, 2024 · strength 0.23
- Zhe Yang · 1 shared paper, 2023 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.